Clinical Trials Sponsored by CellHealth Institute

Total 74945 results

National Cancer Institute (NCI)

Completed

Chile Biliary Longitudinal Study

Gallbladder Cancer | Nutritional and Metabolic Diseases

Chile
National Cancer Institute (NCI)

Terminated

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

Lymphoma

United States
National Cancer Institute (NCI)

Completed

Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

Medullary Thyroid Cancer (MTC)

United States
National Cancer Institute (NCI)

Completed

Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)

Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Tumors (Others)

United States
National Cancer Institute (NCI)

Completed

Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic

United States
National Cancer Institute (NCI)

Completed

Case-Control Study of Inflammatory Breast Cancer in North Africa

Diabetes

Egypt, Tunisia, Morocco
National Cancer Institute (NCI)

Completed

Long-Term Stability of Oral Microbiome Samples

Oral Microbiota | Long Term Sample Stability

United States
National Cancer Institute (NCI)

Completed

Stomach and Esophageal Cancers in Northern Iran

Esophageal Cancer

Iran, Islamic Republic of
National Cancer Institute (NCI)

Completed

Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China

Nasopharyngeal Cancinoma (NPC)

China
National Cancer Institute (NCI)

Completed

Study of Lymphoma in Asia

Lymphoma, Follicular | Lymphoma, Non-Hodgkin | Leukemia | Hodgkin Lymphoma | Multiple Myleoma | Lympocytic, Follicular

China, Hong Kong, Taiwan
National Cancer Institute (NCI)

Completed

Study of Variation Over Time in the Oral Microbiome

Oral Health | Microbiota | Body Mass Index

United States
National Cancer Institute (NCI)

Completed

Cancer Markers Associated With Occupational Exposure to Trichloroethylene

Neoplasms | Epidemiology | Industrial Hygiene

China
National Cancer Institute (NCI)

Completed

Sun Exposure and Melanoma in Agricultural Workers

Melanoma

United States
National Cancer Institute (NCI)

Completed

Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Extended Follow-up of Columbia, MO Serum Bank Participants

Breast Cancer | Ovarian Cancer | Endometrial Cancer

United States
National Cancer Institute (NCI)

Terminated

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Neuroendocrine Tumors | Carcinoma, Neuroendocrine | Neuroendocrine Carcinoma | Neuroendocrine Neoplasms | Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas

United States
National Cancer Institute (NCI)

Completed

A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen

Testicular Cancer

United States
National Cancer Institute (NCI)

Terminated

BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment

Ovarian Cancer

United States
Northwestern University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men (t2p)

Human Papillomavirus

United States
National Cancer Institute (NCI)

Completed

Genetics of Familial Testicular Cancer

Testicular Cancer

United States
National Cancer Institute (NCI)

Completed

Colorectal Neoplasia Screening w Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Ctrs: The CONCeRN Trial

Colorectal Adenoma

United States
National Cancer Institute (NCI)

Completed

Molecular Staging of Endometrial Cancer

Endometrial Cancer

United States
National Cancer Institute (NCI)

Completed

Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability Testing

Lymphomas | Leukemias | Multiple Cancers

United States
National Cancer Institute (NCI)

Withdrawn

E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

United States
National Cancer Institute (NCI)

Completed

Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Cigarette Smoking and Oral Microbiota

Lung Cancer | Oral Cancer | Microbiota

United States
National Cancer Institute (NCI)

Completed

Genetic Epidemiology of Lung Cancer and Smoking

Lung Cancer

Italy
National Cancer Institute (NCI)

Completed

Genes Involved in Resistance or Susceptibility to Hepatitis B Virus

Hepatitis, Viral, Human

China
National Cancer Institute (NCI)

Completed

A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China

Biliary Tract Cancer

China
National Cancer Institute (NCI)

Completed

Genetic Susceptibility to Oncogenic Viruses

HIV Infections | Liver Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Melanoma | Colon Cancer | Gastrointestinal Cancer | Hepatocellular Cancer | Genitourinary Cancer

United States
National Cancer Institute (NCI)

Completed

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

AIDS-Related-Primary Central Nervous System Lymphoma

United States
National Cancer Institute (NCI)

Completed

Intestine Bacteria and Breast Cancer Risk

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data

Neoplasm | Healthcare Disparities | Health Services Accessibility | Outcome Assessment

United States
National Cancer Institute (NCI)

Completed

Differential Influences of Integral and Incidental Emotion on Cancer-related Judgments and Decision Making

Obesity | Cancer | Overweight

United States
National Cancer Institute (NCI)

Completed

Polyp Prevention Trial

Adenoma | Polyps | Diet

United States
National Cancer Institute (NCI)

Completed

Radiation Therapy and the Natural History of Childhood Cancers

Cancer | Childhood Malignancy

United States
National Cancer Institute (NCI)

Completed

A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area

Hepatitis, Viral, Human | Carcinoma, Hepatocellular | Hepatitis, Chronic | Hepatitis, Alcoholic | Liver Cirrhosis, Alcoholic

United States
National Cancer Institute (NCI)

Completed

Cervix Image Sharing Protocol (CISP)

Cervical Cancer | Cervical Abnormalities

United States
National Cancer Institute (NCI)

Completed

Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics

Uterine Diseases | Gonadal Disorders | Breast Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms

Poland
National Cancer Institute (NCI)

Completed

The Ghana Breast Health Study

Breast Neoplasms

Ghana
National Cancer Institute (NCI)

Completed

Questionnaire Pre-Test Study

Cancer

United States
National Cancer Institute (NCI)

Completed

Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health

Bladder Cancer

United States
National Cancer Institute (NCI)

Completed

Biomarkers for Breast Cancer Risk in African American Women

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Analyses of Human Samples Collected in Clinical Trials

Leukemia, Myeloid | Neoplasm Metastasis | Prostate Cancer | Leukemia, Lymphoid

United States, Netherlands
National Cancer Institute (NCI)

Completed

Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease

Sclerotic Graft Versus Host Disease | Imatinib Mesylate

United States
National Cancer Institute (NCI)

Withdrawn

Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatocellular Cancer

United States
National Cancer Institute (NCI)

Terminated

Costa Rican Natural History Study of HPV and Cervical Neoplasia

Cervical Neoplasia

Costa Rica
National Cancer Institute (NCI)

Completed

Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident

Thyroid Cancer | Non-Cancer Thyroid Disease | Non Thyroid Cancer

Belarus
National Cancer Institute (NCI)

Terminated

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Graft vs Host Disease | Graft-Versus-Host Disease | Chronic Graft vs. Host Disease

United States

Clinical Trials Sponsored by CellHealth Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations